MISSION Therapeutics Company
Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Industry:
Mitochondrial Dynamics
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Investment Stage:
N/A
Investor Type:
N/A
Funding Status:
Late Stage Venture
Number Of Exists:
N/A
Technology:
Cancer
Founded Date:
2011